PISI, Giordana
PISI, Giordana
An Overview of the Obese-Asthma Phenotype in Children
2022-01-01 Fainardi, V.; Passadore, L.; Labate, M.; Pisi, G.; Esposito, S.
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation
2019-01-01 Teopompi, E.; Rise, P.; Pisi, R.; Buccellati, C.; Aiello, M.; Pisi, G.; Tripodi, C.; Fainardi, V.; Clini, E.; Chetta, A.; Enrico Rovati, G.; Sala, A.
Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis
2022-01-01 Fainardi, V.; Sodini, C.; Deolmi, M.; Ciuni, A.; Skenderaj, K.; Stabile, M. B.; Neglia, C.; Zani, E. M.; Spaggiari, C.; Sverzellati, N.; Esposito, S.; Pisi, G.
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age
2021-01-01 Esposito, S.; Dal Canto, G.; Caramia, M. R.; Fainardi, V.; Pisi, G.; Principi, N.
Coronavirus infections in children: From SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features
2020-01-01 Iannarella, R.; Lattanzi, C.; Cannata, G.; Argentiero, A.; Neglia, C.; Fainardi, V.; Pisi, G.; Esposito, S.
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system
2021-01-01 Pisi, R.; Aiello, M.; Frizzelli, A.; Calzetta, L.; Marchi, L.; Bertorelli, G.; Pisi, G.; Chetta, A.
Management of infants with brief resolved unexplained events (Brue) and apparent life-threatening events (alte): A rand/ucla appropriateness approach
2021-01-01 Prezioso, G.; Perrone, S.; Biasucci, G.; Pisi, G.; Fainardi, V.; Strisciuglio, C.; Nonnis Marzano, F.; Moretti, S.; Pisani, F.; Tchana, B.; Argentiero, A.; Neglia, C.; Caffarelli, C.; Bertolini, P.; Bersini, M. T.; Canali, A.; Voccia, E.; Squarcia, A.; Ghi, T.; Verrotti, C.; Frusca, T.; Cecchi, R.; Giordano, G.; Colasanti, F.; Roccia, I.; Palanza, P.; Esposito, S.
Prevalence of Scoliosis in Children and Adolescents with Cystic Fibrosis
2024-01-01 Fainardi, V.; Nora, M.; Salghetti, A.; Petraglia, F.; Fanzaghi, P.; Anelli, G.; Cattabiani, M.; Scopelliti, G.; Deolmi, M.; Ferrari, I.; Longo, F.; Esposito, S.; Pisi, G.
Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function
2019-01-01 Di Paolo, M.; Teopompi, E.; Savi, D.; Crisafulli, E.; Longo, C.; Tzani, P.; Longo, F.; Ielpo, A.; Pisi, G.; Cimino, G.; Simmonds, N. J.; Alberto Neder, J.; Chetta, A.; Palange, P.
Role of respiratory syncytial virus in pediatric pneumonia
2020-01-01 Bianchini, S.; Silvestri, E.; Argentiero, A.; Fainardi, V.; Pisi, G.; Esposito, S.
Silence of the lambs: The immunological and molecular mechanisms of covid-19 in children in comparison with adults
2021-01-01 Cusenza, F.; Davino, G.; D'Alvano, T.; Argentiero, A.; Fainardi, V.; Pisi, G.; Principi, N.; Esposito, S.
State of the art on approved cystic fibrosis transmembrane conductance regulator (Cftr) modulators and triple-combination therapy
2021-01-01 Meoli, A.; Fainardi, V.; Deolmi, M.; Chiopris, G.; Marinelli, F.; Caminiti, C.; Esposito, S.; Pisi, G.
The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia
2022-01-01 Esposito, S.; Argentiero, A.; Rebecchi, F.; Fainardi, V.; Pisi, G.; Principi, N.
The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis
2019-01-01 Crisafulli, E.; Teopompi, E.; Luceri, S.; Longo, F.; Tzani, P.; Pagano, P.; Ielpo, A.; Longo, C.; Di Paolo, M.; Sverzellati, N.; Palange, P.; Chetta, A.; Pisi, G.
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume
2021-01-01 Pisi, R.; Aiello, M.; Calzetta, L.; Frizzelli, A.; Alfieri, V.; Bertorelli, G.; Pisi, G.; Chetta, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An Overview of the Obese-Asthma Phenotype in Children | 1-gen-2022 | Fainardi, V.; Passadore, L.; Labate, M.; Pisi, G.; Esposito, S. | |
| Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation | 1-gen-2019 | Teopompi, E.; Rise, P.; Pisi, R.; Buccellati, C.; Aiello, M.; Pisi, G.; Tripodi, C.; Fainardi, V.; Clini, E.; Chetta, A.; Enrico Rovati, G.; Sala, A. | |
| Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis | 1-gen-2022 | Fainardi, V.; Sodini, C.; Deolmi, M.; Ciuni, A.; Skenderaj, K.; Stabile, M. B.; Neglia, C.; Zani, E. M.; Spaggiari, C.; Sverzellati, N.; Esposito, S.; Pisi, G. | |
| Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age | 1-gen-2021 | Esposito, S.; Dal Canto, G.; Caramia, M. R.; Fainardi, V.; Pisi, G.; Principi, N. | |
| Coronavirus infections in children: From SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features | 1-gen-2020 | Iannarella, R.; Lattanzi, C.; Cannata, G.; Argentiero, A.; Neglia, C.; Fainardi, V.; Pisi, G.; Esposito, S. | |
| Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system | 1-gen-2021 | Pisi, R.; Aiello, M.; Frizzelli, A.; Calzetta, L.; Marchi, L.; Bertorelli, G.; Pisi, G.; Chetta, A. | |
| Management of infants with brief resolved unexplained events (Brue) and apparent life-threatening events (alte): A rand/ucla appropriateness approach | 1-gen-2021 | Prezioso, G.; Perrone, S.; Biasucci, G.; Pisi, G.; Fainardi, V.; Strisciuglio, C.; Nonnis Marzano, F.; Moretti, S.; Pisani, F.; Tchana, B.; Argentiero, A.; Neglia, C.; Caffarelli, C.; Bertolini, P.; Bersini, M. T.; Canali, A.; Voccia, E.; Squarcia, A.; Ghi, T.; Verrotti, C.; Frusca, T.; Cecchi, R.; Giordano, G.; Colasanti, F.; Roccia, I.; Palanza, P.; Esposito, S. | |
| Prevalence of Scoliosis in Children and Adolescents with Cystic Fibrosis | 1-gen-2024 | Fainardi, V.; Nora, M.; Salghetti, A.; Petraglia, F.; Fanzaghi, P.; Anelli, G.; Cattabiani, M.; Scopelliti, G.; Deolmi, M.; Ferrari, I.; Longo, F.; Esposito, S.; Pisi, G. | |
| Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function | 1-gen-2019 | Di Paolo, M.; Teopompi, E.; Savi, D.; Crisafulli, E.; Longo, C.; Tzani, P.; Longo, F.; Ielpo, A.; Pisi, G.; Cimino, G.; Simmonds, N. J.; Alberto Neder, J.; Chetta, A.; Palange, P. | |
| Role of respiratory syncytial virus in pediatric pneumonia | 1-gen-2020 | Bianchini, S.; Silvestri, E.; Argentiero, A.; Fainardi, V.; Pisi, G.; Esposito, S. | |
| Silence of the lambs: The immunological and molecular mechanisms of covid-19 in children in comparison with adults | 1-gen-2021 | Cusenza, F.; Davino, G.; D'Alvano, T.; Argentiero, A.; Fainardi, V.; Pisi, G.; Principi, N.; Esposito, S. | |
| State of the art on approved cystic fibrosis transmembrane conductance regulator (Cftr) modulators and triple-combination therapy | 1-gen-2021 | Meoli, A.; Fainardi, V.; Deolmi, M.; Chiopris, G.; Marinelli, F.; Caminiti, C.; Esposito, S.; Pisi, G. | |
| The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia | 1-gen-2022 | Esposito, S.; Argentiero, A.; Rebecchi, F.; Fainardi, V.; Pisi, G.; Principi, N. | |
| The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis | 1-gen-2019 | Crisafulli, E.; Teopompi, E.; Luceri, S.; Longo, F.; Tzani, P.; Pagano, P.; Ielpo, A.; Longo, C.; Di Paolo, M.; Sverzellati, N.; Palange, P.; Chetta, A.; Pisi, G. | |
| Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume | 1-gen-2021 | Pisi, R.; Aiello, M.; Calzetta, L.; Frizzelli, A.; Alfieri, V.; Bertorelli, G.; Pisi, G.; Chetta, A. |